UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 515

Sortiert nach

Salivary duct carcinoma: An aggressive salivary gland malignancy with opportunities for targeted therapy

Oral oncology, 2017-11, Vol.74, p.40-48

2017

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of MDSC Trafficking with SX-682, a CXCR1/2 Inhibitor, Enhances NK-Cell Immunotherapy in Head and Neck Cancer Models

Clinical cancer research, 2020-03, Vol.26 (6), p.1420-1431

2020

Link zum Volltext

Verfügbarkeit prüfen

The Role of HPV in Cancer Prognosis-Location, Location, Location

JAMA otolaryngology-- head & neck surgery, 2022-01, Vol.148 (1), p.79

Schmitt, Nicole C

2022

Link zum Volltext

Verfügbarkeit prüfen

Cardiac potassium channel subtypes: new roles in repolarization and arrhythmia

Physiological reviews, 2014-04, Vol.94 (2), p.609-653

2014

Link zum Volltext

Verfügbarkeit prüfen

Cisplatin and oxaliplatin induce similar immunogenic changes in preclinical models of head and neck cancer

Oral oncology, 2019-08, Vol.95, p.127-135

2019

Link zum Volltext

Verfügbarkeit prüfen

A 20-Year Review of 75 Cases of Salivary Duct Carcinoma

JAMA otolaryngology-- head & neck surgery, 2016-05, Vol.142 (5), p.489

2016

Link zum Volltext

Verfügbarkeit prüfen

Adaptive resistance to anti-PD1 therapy by Tim-3 upregulation is mediated by the PI3K-Akt pathway in head and neck cancer

Oncoimmunology, 2017-01, Vol.6 (1), p.e1261779-e1261779

2017

Link zum Volltext

Verfügbarkeit prüfen

Characterization of the tumor microenvironment in the mouse oral cancer (MOC1) model after orthotopic implantation in the buccal mucosa

Head & neck, 2024-05, Vol.46 (5), p.1056-1062

2024

Link zum Volltext

Verfügbarkeit prüfen

PD-1 Status in CD8 + T Cells Associates with Survival and Anti-PD-1 Therapeutic Outcomes in Head and Neck Cancer

Cancer research (Chicago, Ill.), 2017-11, Vol.77 (22), p.6353-6364

2017

Link zum Volltext

Verfügbarkeit prüfen

HPV in non-oropharyngeal head and neck cancer: does it matter?

Annals of translational medicine, 2020-09, Vol.8 (18), p.1120-1120

Schmitt, Nicole C

2020

Link zum Volltext

Verfügbarkeit prüfen

Laryngeal Anatomy, Molecular Biology, Cause, and Risk Factors for Laryngeal Cancer

Otolaryngologic clinics of North America, 2023-04, Vol.56 (2), p.197

2023

Link zum Volltext

Verfügbarkeit prüfen

Dual Antagonist of cIAP/XIAP ASTX660 Sensitizes HPV - and HPV + Head and Neck Cancers to TNFα, TRAIL, and Radiation Therapy

Clinical cancer research, 2019-11, Vol.25 (21), p.6463-6474

2019

Link zum Volltext

Verfügbarkeit prüfen

Cisplatin Alters Antitumor Immunity and Synergizes with PD-1/PD-L1 Inhibition in Head and Neck Squamous Cell Carcinoma

Cancer immunology research, 2017-12, Vol.5 (12), p.1141-1151

2017

Link zum Volltext

Verfügbarkeit prüfen

Developing an enhanced 7-color multiplex IHC protocol to dissect immune infiltration in human cancers

PloS one, 2021-02, Vol.16 (2), p.e0247238-e0247238

2021

Link zum Volltext

Verfügbarkeit prüfen

Atorvastatin is associated with reduced cisplatininduced hearing loss

The Journal of clinical investigation, 2021-01, Vol.131 (1), p.1-11

2021

Link zum Volltext

Verfügbarkeit prüfen

Antibiotic Prophylaxis in Patients Undergoing Head and Neck Free Flap Reconstruction

JAMA otolaryngology-- head & neck surgery, 2015-12, Vol.141 (12), p.1096

2015

Link zum Volltext

Verfügbarkeit prüfen

Identifying risk factors for the prognosis of head and neck cutaneous squamous cell carcinoma: A systematic review and meta-analysis

PloS one, 2020-09, Vol.15 (9), p.e0239586-e0239586

2020

Link zum Volltext

Verfügbarkeit prüfen

Human papillomavirus 16 E6 antibodies are sensitive for human papillomavirus–driven oropharyngeal cancer and are associated with recurrence

Cancer, 2017-11, Vol.123 (22), p.4382-4390

2017

Link zum Volltext

Verfügbarkeit prüfen

Atorvastatin is associated with reduced cisplatin-induced hearing loss

The Journal of clinical investigation, 2021-01, Vol.131 (1)

2021

Link zum Volltext

Verfügbarkeit prüfen

Hydroxychloroquine (HCQ) decreases the benefit of anti-PD-1 immune checkpoint blockade in tumor immunotherapy

PloS one, 2021-06, Vol.16 (6), p.e0251731

2021

Link zum Volltext

Verfügbarkeit prüfen

Combined IL6 and CCR2 blockade potentiates antitumor activity of NK cells in HPV-negative head and neck cancer

Journal of experimental & clinical cancer research, 2024-03, Vol.43 (1), p.76-76

2024

Link zum Volltext

Verfügbarkeit prüfen

Chemoradiation-induced hearing loss remains a major concern for head and neck cancer patients

International journal of audiology, 2018-08, Vol.57 (sup4), p.S48-S53

2018

Link zum Volltext

Verfügbarkeit prüfen

PD-1 Inhibition Minimally Affects Cisplatin-Induced Toxicities in a Murine Model

Otolaryngology-head and neck surgery, 2018-08, Vol.159 (2), p.343-346

2018

Link zum Volltext

Verfügbarkeit prüfen

ASTX660, an antagonist of cIAP1/2 and XIAP, increases antigen processing machinery and can enhance radiation-induced immunogenic cell death in preclinical models of head and neck cancer

Oncoimmunology, 2020-01, Vol.9 (1), p.1710398-1710398

2020

Link zum Volltext

Verfügbarkeit prüfen

Role of HER2 in Prognosis of Salivary Duct Carcinoma: A Systematic Review and Meta‐Analysis

The Laryngoscope, 2023-03, Vol.133 (3), p.476-484

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 515

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(417)
Mit Volltextzugriff
(426)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(282)
Life Sciences & Biomedicine
(245)
Humans
(176)
Animals
(94)
Female
(93)
Male
(80)
Oncology
(55)
Adult
(54)
Middle Aged
(47)
Medicine
(34)
Mutation
(32)
Mice
(31)
Biological And Medical Sciences
(30)
Aged
(28)
Biochemistry & Molecular Biology
(26)
Cell Biology
(26)
Immunology
(24)
Head And Neck Cancer
(23)
Science & Technology - Other Topics
(23)
Tumors
(23)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Salivary duct carcinoma: An aggressive salivary gland malignancy with opportunities for targeted therapy

Inhibition of MDSC Trafficking with SX-682, a CXCR1/2 Inhibitor, Enhances NK-Cell Immunotherapy in Head and Neck Cancer Models

The Role of HPV in Cancer Prognosis-Location, Location, Location

Cardiac potassium channel subtypes: new roles in repolarization and arrhythmia

Cisplatin and oxaliplatin induce similar immunogenic changes in preclinical models of head and neck cancer

A 20-Year Review of 75 Cases of Salivary Duct Carcinoma

Adaptive resistance to anti-PD1 therapy by Tim-3 upregulation is mediated by the PI3K-Akt pathway in head and neck cancer

Characterization of the tumor microenvironment in the mouse oral cancer (MOC1) model after orthotopic implantation in the buccal mucosa

PD-1 Status in CD8 + T Cells Associates with Survival and Anti-PD-1 Therapeutic Outcomes in Head and Neck Cancer

HPV in non-oropharyngeal head and neck cancer: does it matter?

Laryngeal Anatomy, Molecular Biology, Cause, and Risk Factors for Laryngeal Cancer

Dual Antagonist of cIAP/XIAP ASTX660 Sensitizes HPV - and HPV + Head and Neck Cancers to TNFα, TRAIL, and Radiation Therapy

Cisplatin Alters Antitumor Immunity and Synergizes with PD-1/PD-L1 Inhibition in Head and Neck Squamous Cell Carcinoma

Developing an enhanced 7-color multiplex IHC protocol to dissect immune infiltration in human cancers

Atorvastatin is associated with reduced cisplatininduced hearing loss

Antibiotic Prophylaxis in Patients Undergoing Head and Neck Free Flap Reconstruction

Identifying risk factors for the prognosis of head and neck cutaneous squamous cell carcinoma: A systematic review and meta-analysis

Human papillomavirus 16 E6 antibodies are sensitive for human papillomavirus–driven oropharyngeal cancer and are associated with recurrence

Atorvastatin is associated with reduced cisplatin-induced hearing loss

Hydroxychloroquine (HCQ) decreases the benefit of anti-PD-1 immune checkpoint blockade in tumor immunotherapy

Combined IL6 and CCR2 blockade potentiates antitumor activity of NK cells in HPV-negative head and neck cancer

Chemoradiation-induced hearing loss remains a major concern for head and neck cancer patients

PD-1 Inhibition Minimally Affects Cisplatin-Induced Toxicities in a Murine Model

ASTX660, an antagonist of cIAP1/2 and XIAP, increases antigen processing machinery and can enhance radiation-induced immunogenic cell death in preclinical models of head and neck cancer

Role of HER2 in Prognosis of Salivary Duct Carcinoma: A Systematic Review and Meta‐Analysis

Suchergebnisse filtern